June 1, 2012
- Kasznar Leonardos
Newsletter 2012.03 – The debate over ANVISA’s role in the examination of pharmaceutical patent applications continues
As you may be aware, due to article 229-C of the Brazilian IP Law, as amended by Law No. 10,196/01, whenever a patent application claims a pharmaceutical product or process, consent from the National Sanitary Surveillance Agency (ANVISA) is also required prior to granting the desired patent. This provision, however, has been the source of never-ending controversy and subject to growing attacks since it entered into effect in 2001.
The lack of statutory power of ANVISA to analyse patentability requirements of pharma applications was supported by the Attorney-General’s Office in legal opinions published in 2009 and 2011. Indeed, in their opinion, ANVISA should only make health-based assessments of applications sent for prior consent; prior consent should only be denied to applications in instances that granting the patents would pose health risks. How ANVISA would assess “health risks” on the basis of the information included in patent applications was left unanswered though.
Last related news
February 1, 2024
Betting Market and the Creation of the Secretariat of Prizes and Bets by Decree 11.907/2024
On Wednesday, January 31, 2024, Decree No. 11.907/2024 was published in the Official Gazette, creating the Secretariat of Prizes and Bets (SPA) … Betting Market and the Creation of the Secretariat of Prizes and Bets by Decree 11.907/2024
January 19, 2024
New Law expands Ancine’s role in the fight against piracy of audiovisual content
The enactment of Law No. 14,815 on January 16 of this year marks a significant milestone in the fight against piracy of … New Law expands Ancine’s role in the fight against piracy of audiovisual content
January 9, 2024
Decree regulates the free provision of cannabidiol-based medications by the Unified Health System of São Paulo
On December 26, 2023, Decree No. 68,233/2023 was published in the Official Gazette of São Paulo, regulating the free provision of cannabidiol … Decree regulates the free provision of cannabidiol-based medications by the Unified Health System of São Paulo